NCT03053570 is a NA clinical trial of Cryoballoon in Persistent Atrial Fibrillation, sponsored by China Cardiometabolic Registries.

Who is sponsoring NCT03053570?

NCT03053570 is sponsored by China Cardiometabolic Registries.

What drugs are being tested in NCT03053570?

Interventions in NCT03053570: Cryoballoon, Radiofrequency Energy(Contact Force).

What condition does NCT03053570 study?

NCT03053570 studies Persistent Atrial Fibrillation.

Is NCT03053570 still recruiting?

NCT03053570 is currently status unknown. Last updated 15 February 2017.

Last reviewed 2017-02-15 · How we verify

NCT03053570

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Comparing Pulmonary Vein Isolation With the Cryoballoon and Radiofrequency Energy(Contact Force) in the Treatment of Persistent Atrial Fibrillation (AF) (Cryo Vs CF in PerAF)

Status unknown NA Last updated 15 February 2017

What this trial tests

NA trial testing Cryoballoon in Persistent Atrial Fibrillation in 200 participants. Status unknown.

Timeline

1 March 2017

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	China Cardiometabolic Registries
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	200
Start date	1 March 2017
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across China

Drugs / interventions tested

Cryoballoon
Radiofrequency Energy(Contact Force)

Conditions studied

Persistent Atrial Fibrillation — all drugs for Persistent Atrial Fibrillation →

Sponsor

China Cardiometabolic Registries

Who can join

Adults 18 to 75, any sex, with Persistent Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to perform a prospective, randomised study investigating the safety and efficacy of cryoballoon catheter ablation compared with radiofrequency ablation(contact force), in the treatment of persistent AF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Persistent Atrial Fibrillation

Currently open trials in the same condition.

NCT07298473 — Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp · NA · recruiting
NCT07535268 — REPRESENT-PF Registry · recruiting
NCT07508618 — Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule · Phase 4 · recruiting
NCT07116525 — A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter · NA · recruiting
NCT07106970 — PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03053570 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by China Cardiometabolic Registries
Last refreshed: 15 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03053570.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing